LP
ABEO icon

LMR Partners’s Abeona Therapeutics ABEO Stock Holding History

LMR Partners’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,120
Closed -$129K – 1355
2025
Q1 		$129K Buy
+27,120
New +$147K ﹤0.01% 1116
2021
Q3 		– Sell
-1,544
Closed -$60K – 976
2021
Q2 		$60K Buy
+1,544
New +$63K ﹤0.01% 960

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

LMR Partners's ABEO Position: Q2 2025 in Review

LMR Partners sold out of Abeona Therapeutics (ABEO) in Q2 2025, closing a stake of 27,120 shares — an estimated $129K sold.

LMR Partners first reported a position in ABEO in Q2 2021 and held it in 2 quarters. The position peaked at $129K in Q1 2025. 95 funds tracked by Wall St. Rank hold ABEO as of Q2 2025.

  • LMR Partners reported no remaining Abeona Therapeutics position as of Q2 2025 after selling out during the quarter.
  • LMR Partners sold 27,120 Abeona Therapeutics shares in Q2 2025, an estimated $129K.
  • LMR Partners first reported a position in Abeona Therapeutics in Q2 2021 and held it in 2 quarters.
  • LMR Partners's Abeona Therapeutics position peaked at $129K in Q1 2025.
  • 95 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2025.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.